GO:0070315 G1 to G0 transition involved in cell differentiation: Cell Cycle Exit, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070315 describes a cell cycle arrest process that results in arrest during G1 phase, whereupon the cell enters G0 phase, in the context of cell differentiation.
• The transition is a programmed exit from the proliferative cycle that is required for terminal differentiation of many cell types.
• Key regulators include protein kinase C signaling, CD20 in B cells, DDX5, and voltage-gated sodium channels, as shown in diverse experimental systems.
• Dysregulation of G1 to G0 transition is linked to cancer, impaired neurogenesis, and aberrant adipocyte differentiation.
• CRISPR knockout, point mutation, knock-in, and overexpression models enable causal testing of candidate genes in this process.
• Methods such as RNA-seq, Ribo-seq, proteomics, and live-cell imaging are used to resolve the molecular events of G1/G0 arrest.
Description
The Gene Ontology term GO:0070315, G1 to G0 transition involved in cell differentiation, defines a cell cycle arrest process that results in arrest during G1 phase, whereupon the cell enters G0 phase, in the context of cell differentiation. This process is a fundamental mechanism by which proliferating cells exit the cell cycle and commit to a differentiated state. It is distinct from quiescence in non-differentiating contexts because it is explicitly coupled to developmental or differentiation programs. Understanding this transition is essential for researchers studying tissue development, regeneration, and cancer, where loss of differentiation-associated arrest is a hallmark of malignancy. The transition is regulated by extracellular signals and intracellular pathways that converge on the G1/S checkpoint machinery. For example, protein kinase C-mediated signaling has been shown to regulate cell cycle progression and arrest. In B cells, the CD20 antigen is involved in activation from G0 to G1, highlighting the reversibility and context-dependence of these states. The DDX5 protein has been implicated in both cell proliferation and differentiation, suggesting a role in coordinating the switch between these programs. Recent studies in neurospheres and glioblastoma models demonstrate that driving cells out of the cell cycle can promote differentiation and sensitize tumor cells to therapy. Thus, GO:0070315 represents a convergence point for developmental biology, cancer research, and regenerative medicine.
G1 to G0 transition involved in cell differentiation At A Glance
| GO ID | GO:0070315 |
|---|---|
| GO term | G1 to G0 transition involved in cell differentiation |
| Ontology | biological_process |
| Synonym | G1/G0 transition involved in cell differentiation |
| Major function | Cell cycle arrest during G1 phase leading to G0 entry in the context of cell differentiation |
| Related processes | Cell cycle arrest, differentiation, quiescence |
| Cellular context | Various cell types including B cells, neurospheres, adipocytes, glioblastoma cells |
| Key regulators | Protein kinase C, CD20, DDX5, voltage-gated sodium channels |
What Is GO:0070315?
In plain terms, GO:0070315 describes the moment when a dividing cell stops progressing through the G1 phase and enters a resting, non-dividing state called G0, specifically as part of becoming a specialized cell type. This is not a passive event but an actively regulated process that couples cell cycle exit to differentiation programs. The QuickGO definition states: A cell cycle arrest process that results in arrest during G1 phase, whereupon the cell enters G0 phase, in the context of cell differentiation. The synonym G1/G0 transition involved in cell differentiation is also used. This term is a biological process and should not be confused with generic quiescence or senescence, as it is explicitly tied to differentiation.
Why Is G1 to G0 transition involved in cell differentiation Important in Cell Biology?
GO:0070315 is important because it defines the mechanistic link between cell cycle control and differentiation, a process that is essential for normal development and tissue homeostasis. When this transition is disrupted, cells may continue to proliferate instead of differentiating, contributing to tumorigenesis and other diseases. For example, in glioblastoma, modulating ion channels to enhance differentiation and cell cycle exit can sensitize cells to chemotherapy. In neurogenesis, methamphetamine exposure drives cell cycle exit and aberrant differentiation in hippocampal-derived neurospheres, illustrating how external insults can hijack this process. In adipocytes, circADAMTS16 inhibits differentiation and promotes proliferation, showing that non-coding RNAs can regulate the balance between these states. Therefore, understanding GO:0070315 provides insights into developmental disorders, cancer, and regenerative strategies.
• Required for terminal differentiation of many cell types, including neurons, adipocytes, and B cells.
• Dysregulation leads to uncontrolled proliferation and cancer, as seen in glioblastoma and breast cancer models.
• Modulating the transition can enhance differentiation therapy in oncology.
• Environmental factors such as methamphetamine can aberrantly drive cell cycle exit and differentiation.
• Non-coding RNAs and RNA-binding proteins like DDX5 regulate the balance between proliferation and differentiation.
• Protein kinase C signaling is a key regulator of cell cycle arrest and differentiation.
• CD20-mediated B cell activation from G0 to G1 highlights the reversibility of quiescent states.
• Ribosome incorporation can induce EMT-like phenomena with cell cycle arrest, linking translation to this transition.
• Understanding the transition aids in developing regenerative medicine strategies.
• CRISPR-based models allow causal dissection of genes involved in G1/G0 arrest.
What Happens During G1 to G0 transition involved in cell differentiation?
Integration of Differentiation Signals
In simple terms: The cell receives external and internal cues that tell it to stop dividing and start becoming a specialized cell.
Differentiation signals, such as growth factor withdrawal or lineage-specific transcription factors, converge on the cell cycle machinery to inhibit G1 progression. Protein kinase C signaling has been shown to regulate cell cycle progression and arrest, acting as a node that integrates diverse signals. In B cells, the CD20 antigen is involved in activation from G0 to G1, indicating that surface receptors can modulate the transition in a cell-type-specific manner. The DDX5 protein is involved in both proliferation and differentiation, suggesting it may help coordinate the decision to exit the cycle.
G1 Phase Arrest
In simple terms: The cell stops moving forward in the G1 phase and pauses before copying its DNA.
During G1 arrest, the activity of cyclin-dependent kinases (CDKs) is suppressed, preventing phosphorylation of the retinoblastoma protein and thus blocking S-phase entry. This arrest is a prerequisite for entering G0. Studies in neurospheres show that methamphetamine exposure drives cell cycle exit, likely by inducing G1 arrest. In glioblastoma cells, modulation of voltage-gated sodium channels enhances differentiation and leads to cell cycle arrest, demonstrating that ion channel activity can influence this checkpoint.
Entry into G0 Phase
In simple terms: The cell enters a resting state called G0, where it no longer prepares to divide.
Once in G0, the cell exits the active cell cycle and may remain quiescent or proceed to terminal differentiation. This state is characterized by low metabolic activity for proliferation and altered gene expression. In bovine adipocytes, circADAMTS16 inhibits differentiation and promotes proliferation, implying that its downregulation may facilitate G0 entry and differentiation. Ribosome incorporation in breast cancer cells induces an EMT-like phenomenon with cell cycle arrest, suggesting a link between translational machinery and G0 entry.
Commitment to Differentiation
In simple terms: The cell begins to express the genes that give it its specialized identity.
After G0 entry, differentiation-specific genes are activated. This commitment is often irreversible and involves changes in chromatin structure and transcription factor networks. In gonocytes, the establishment of male germline identity involves a transition that likely includes cell cycle exit. The DDX5 protein has been implicated in differentiation, supporting its role in this commitment step.
Key Genes Involved in GO:0070315 G1 to G0 transition involved in cell differentiation
The following genes and proteins have been experimentally linked to the G1 to G0 transition involved in cell differentiation, based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CD20 (MS4A1) | B cell activation from G0 to G1 | Surface marker; target for B cell studies |
| DDX5 | RNA helicase involved in proliferation and differentiation | Regulator of the switch between growth and differentiation |
| PRKCA (PKC-alpha) | Protein kinase C-mediated cell cycle regulation | Key signaling node for arrest and differentiation |
| SCN5A (Nav1.5) | Voltage-gated sodium channel | Modulation enhances differentiation in glioblastoma |
| SCN9A (Nav1.7) | Voltage-gated sodium channel | Potential target for differentiation therapy |
| CircADAMTS16 | Circular RNA regulating adipocyte differentiation | Inhibits differentiation, promotes proliferation |
| miR-10167-3p | microRNA target of circADAMTS16 | Modulates adipocyte differentiation |
| RPL (ribosomal proteins) | Ribosome components | Ribosome incorporation induces EMT-like arrest |
| CDKN1A (p21) | CDK inhibitor | Mediates G1 arrest in differentiation contexts |
| CDKN1B (p27) | CDK inhibitor | Regulates G1 progression and exit |
| RB1 | Retinoblastoma protein | Gatekeeper of G1/S transition |
| TP53 | Tumor suppressor | Induces cell cycle arrest in response to stress |
| MYC | Proliferation driver | Downregulation associated with differentiation |
| CCND1 (Cyclin D1) | G1 progression | Target of PKC signaling |
| CDK4/6 | G1 kinases | Inhibited during G1 arrest |
| E2F1 | Transcription factor | Regulates S-phase genes; repressed in G0 |
| GATA4 | Differentiation transcription factor | Potential downstream effector |
How Is G1 to G0 transition involved in cell differentiation Regulated?
The G1 to G0 transition involved in cell differentiation is regulated by multiple signaling pathways. Protein kinase C (PKC) is a major regulator of cell cycle progression and arrest, with PKC-mediated signaling influencing the expression and activity of cyclins, CDKs, and CDK inhibitors. In B cells, CD20 engagement can drive activation from G0 to G1, indicating that extracellular stimuli can reverse or modulate the transition. The RNA helicase DDX5 has been implicated in both proliferation and differentiation, suggesting it may act as a molecular switch. Additionally, voltage-gated sodium channels can be modulated to enhance differentiation and cell cycle exit in glioblastoma cells, revealing an unexpected role for ion channels in this regulation. Non-coding RNAs, such as circADAMTS16 and its target miR-10167-3p, also regulate the balance between proliferation and differentiation in adipocytes. These diverse regulators converge on the core cell cycle machinery to determine whether a cell remains in G1, exits to G0, or continues cycling.
G1 to G0 transition involved in cell differentiation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| SCN5A | Glioblastoma | Knockout or overexpression in glioblastoma cell lines |
| CD20 (MS4A1) | B cell malignancies and autoimmune diseases | Knockout in B cell lines |
| DDX5 | Cancer and differentiation disorders | Point mutation or knockout in cancer cells |
| CircADAMTS16 | Obesity and metabolic syndrome | Overexpression in adipocytes |
| PRKCA | Cancer and inflammatory diseases | Knockout or point mutation in cell lines |
Cancer and Differentiation Therapy
Loss of the ability to undergo G1 to G0 transition is a hallmark of cancer, where cells continue to proliferate instead of differentiating. In glioblastoma, modulating voltage-gated sodium channels to enhance differentiation and cell cycle exit sensitizes cells to chemotherapy, suggesting that targeting this transition can improve treatment. In breast cancer cells, ribosome incorporation induces an EMT-like phenomenon with cell cycle arrest, linking translational stress to differentiation and arrest. Protein kinase C signaling, which regulates this transition, is often dysregulated in cancer.
Neurodevelopmental and Neurodegenerative Contexts
Proper G1 to G0 transition is critical for neurogenesis. Methamphetamine exposure drives cell cycle exit and aberrant differentiation in rat hippocampal-derived neurospheres, indicating that drugs of abuse can disrupt this process and potentially contribute to neurodevelopmental deficits. The establishment of male germline identity also involves a transition that may be affected in infertility.
Metabolic and Adipocyte Differentiation
In adipocytes, circADAMTS16 inhibits differentiation and promotes proliferation by targeting miR-10167-3p, showing that non-coding RNAs can dysregulate the G1 to G0 transition and contribute to metabolic disorders. Understanding this regulation may offer therapeutic avenues for obesity and diabetes.
From G1 to G0 transition involved in cell differentiation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X cause G1 arrest and differentiation? | CRISPR knockout in a differentiation-competent cell line |
| Does a specific mutation in gene X alter G1/G0 transition? | Point mutation knock-in via CRISPR |
| Does overexpression of gene X drive differentiation? | CRISPR activation or lentiviral overexpression |
| Does tagging gene X affect its function in the transition? | Tagged knock-in (e.g., GFP) for live imaging |
| Which genes are essential for G1/G0 transition? | Genome-wide CRISPR library screening |
| What is the transcriptional profile during transition? | RNA-seq of synchronized cells |
How to Study the G1 to G0 transition involved in cell differentiation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression | Identify differentiation markers and cell cycle genes |
| Ribo-seq | Translated mRNAs | Assess translational changes during arrest |
| Proteomics | Protein abundance and modifications | Quantify CDK inhibitors and signaling proteins |
| Phosphoproteomics | Phosphorylation events | Track CDK activity and PKC signaling |
| Live-cell imaging | Cell cycle phase and morphology | Monitor G1 arrest and differentiation in real time |
| Flow cytometry | DNA content and surface markers | Distinguish G0/G1 and quantify CD20 |
| CRISPR screen | Gene essentiality for transition | Discover novel regulators |
Transcriptomic and Translational Profiling
RNA-seq can capture global changes in gene expression as cells undergo G1 to G0 transition, revealing differentiation markers and cell cycle regulators. Ribo-seq provides a snapshot of actively translated mRNAs, which is particularly relevant given the link between ribosome incorporation and cell cycle arrest. These methods can identify novel regulators and validate known pathways such as PKC signaling.
Proteomic and Phosphoproteomic Analysis
Mass spectrometry-based proteomics can quantify changes in protein abundance and phosphorylation during the transition. This is useful for tracking CDK activity, retinoblastoma protein phosphorylation, and signaling nodes like PKC. It can also reveal post-translational modifications on ion channels that affect differentiation.
Imaging and Flow Cytometry
Live-cell imaging with fluorescent reporters for cell cycle phase (e.g., FUCCI) and differentiation markers allows real-time monitoring of G1 arrest and G0 entry. Flow cytometry can quantify DNA content and surface markers like CD20 to distinguish G0/G1 states. These techniques are essential for validating CRISPR phenotypes.
CRISPR Screening and Functional Genomics
Pooled CRISPR knockout or activation screens can identify genes that regulate the G1 to G0 transition. For example, a screen for drivers of differentiation in neurospheres could uncover novel regulators like DDX5. Bioinformatics analysis of screen data can pinpoint pathways enriched in hits.
How CRISPR Can Be Used to Study GO:0070315 G1 to G0 transition involved in cell differentiation
Knockout
CRISPR knockout of candidate genes such as DDX5 or PRKCA can test whether they are required for G1 to G0 transition. For example, knocking out DDX5 in a differentiation model may impair the ability of cells to exit the cell cycle. Knockout of CD20 in B cells could affect G0 to G1 activation.
Point Mutation
Introducing specific point mutations in genes like SCN5A can dissect the role of ion channel activity in differentiation-associated arrest. This approach can separate channel function from other roles. Point mutations in PRKCA can identify phosphorylation sites critical for cell cycle regulation.
Knock-in
Knock-in of fluorescent tags (e.g., GFP) into endogenous loci such as CDKN1A allows live tracking of protein expression during the transition. This can reveal dynamics of CDK inhibitors as cells enter G0. Knock-in of differentiation markers can also be used to sort cells at different stages.
Overexpression
CRISPR activation or lentiviral overexpression of genes like circADAMTS16 can test sufficiency for inhibiting differentiation. Overexpression of DDX5 may drive proliferation and block differentiation. This approach is useful for validating gain-of-function phenotypes.
How EDITGENE Supports G1 to G0 transition involved in cell differentiation Research
Researchers studying G1 to G0 transition involved in cell differentiation-related genes often need to determine whether a candidate gene is causally involved in the process or merely correlated with it. EDITGENE provides a comprehensive suite of CRISPR-based services to enable such causal experiments, from knockout to precise point mutations and library screening.
Contact EDITGENE today to design your custom CRISPR model for G1 to G0 transition involved in cell differentiation research.
Frequently Asked Questions About G1 to G0 transition involved in cell differentiation
What is GO:0070315?
GO:0070315 is a Gene Ontology biological process term defined as a cell cycle arrest process that results in arrest during G1 phase, whereupon the cell enters G0 phase, in the context of cell differentiation.
What genes are involved in G1 to G0 transition involved in cell differentiation?
Genes such as CD20, DDX5, PRKCA, SCN5A, and circADAMTS16 have been implicated in this transition.
How is G1 to G0 transition different from quiescence?
This term specifically couples the transition to cell differentiation, whereas generic quiescence can occur without differentiation.
What diseases are associated with defects in G1 to G0 transition?
Cancer, neurodevelopmental disorders, and metabolic diseases like obesity have been linked to dysregulation of this process.
What methods are used to study G1 to G0 transition?
Common methods include RNA-seq, Ribo-seq, proteomics, flow cytometry, live-cell imaging, and CRISPR screens.
Can CRISPR be used to study this transition?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools to dissect gene function in this process.
What is the role of protein kinase C in this transition?
Protein kinase C signaling regulates cell cycle progression and arrest, influencing the G1 to G0 transition.
How does CD20 affect the transition?
CD20 is involved in activation of B cells from G0 to G1, indicating it can modulate the transition.
What is the role of DDX5 in differentiation?
DDX5 is involved in both cell proliferation and differentiation, suggesting it helps coordinate the switch.
How can I model G1 to G0 transition in the lab?
You can use differentiation-competent cell lines and manipulate genes with CRISPR, then monitor cell cycle arrest and differentiation markers.
Conclusion
GO:0070315, G1 to G0 transition involved in cell differentiation, is a critical biological process that links cell cycle control to developmental programs. Its dysregulation contributes to cancer, neurodevelopmental disorders, and metabolic diseases. Understanding the molecular players and regulatory mechanisms is essential for developing targeted therapies. EDITGENE offers comprehensive CRISPR services to facilitate causal research into this transition, empowering discoveries in developmental biology and disease.
References
- 1. Golay JT et al.. 1985. The CD20 (Bp35) antigen is involved in activation of B cells from the G0 to the G1 phase of the cell cycle.. J Immunol 135(6):3795-801 PMID: 2415587
- 2. Ponomartsev NV et al.. 2015. [The DDX5 protein is involved in cell proliferation and differentiation].. Tsitologiia 57(2):111-8 PMID: 26035968
- 3. Wang S et al.. 2023. Methamphetamine exposure drives cell cycle exit and aberrant differentiation in rat hippocampal-derived neurospheres.. Front Pharmacol 14:1242109 PMID: 37795025
- 4. Giammello F et al.. 2024. Modulating voltage-gated sodium channels to enhance differentiation and sensitize glioblastoma cells to chemotherapy.. Cell Commun Signal 22(1):434 PMID: 39251990
- 5. Li P et al.. 2026. Gonocytes in Transition: Establishing the Male Germline Identity.. Adv Exp Med Biol 1517:3-16 PMID: 42455434
- 6. Hu C et al.. 2023. CircADAMTS16 Inhibits Differentiation and Promotes Proliferation of Bovine Adipocytes by Targeting miR-10167-3p.. Cells 12(8) PMID: 37190084
- 7. Kudo M et al.. 2022. Ribosome Incorporation Induces EMT-like Phenomenon with Cell Cycle Arrest in Human Breast Cancer Cell.. Cells Tissues Organs 211(2):212-221 PMID: 33640894
- 8. Black JD. 2000. Protein kinase C-mediated regulation of the cell cycle.. Front Biosci 5:D406-23 PMID: 10762593
